mitomycin has been researched along with sirolimus in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mitchell, SA; Subkhankulova, T; Willis, AE | 1 |
| Bisch-Knaden, S; Borner, M; Candinas, D; Egger, B; Inglin, RA; Mettler, D; Wagner, OJ | 1 |
| Buron, F; Héquet, O; Malcus, C; Morelon, E; Moulin, FT; Perrin, H | 1 |
| Chen, JF; Gao, J; Wang, ZH; Zhang, D; Zhu, JY | 1 |
| Al-Batran, SE; Atmaca, A; Jäger, E; Pauligk, C; Pustowka, A; Werner, D | 1 |
| Choudry, HA; Dilly, AK; Kim, SY; Lee, YJ; Song, X | 1 |
| Grąt, M; Kornasiewicz, O; Krasnodębski, M; Krawczyk, M; Patkowski, W; Stankiewicz, R | 1 |
| Akin, MM; Demir, T; Eren, K; Turgut, B | 1 |
| Fu, Q; Huang, HT; Li, J; Liu, LS; Wang, CX; Wang, D; Wang, F; Xiong, YY | 1 |
| Angus, PW; Chin, R; Jia, Z; Lim, EJ; Nachbur, U; Silke, J; Torresi, J | 1 |
| Chaudhury, I; Holz, MK; Knudson, K; Nolan, M | 1 |
| Dion, GR; Jacobsen, C; Johnson, CM; Luke, AS; Novak, N | 1 |
2 review(s) available for mitomycin and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
State of the Science in Tracheal Stents: A Scoping Review.
Topics: Adult; Alloys; Animals; Arsenic Trioxide; Cats; Dogs; Doxycycline; Humans; Magnesium; Mice; Mitomycin; Paclitaxel; Polydioxanone; Polyesters; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polytetrafluoroethylene; Polyurethanes; Rats; Sheep; Silicones; Sirolimus; Steel; Stents; Swine; Tracheal Stenosis | 2022 |
1 trial(s) available for mitomycin and sirolimus
| Article | Year |
|---|---|
Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Esophageal Neoplasms; Everolimus; Female; Humans; Male; Middle Aged; Mitomycin; Sirolimus; Stomach Neoplasms; Survival Analysis | 2013 |
13 other study(ies) available for mitomycin and sirolimus
| Article | Year |
|---|---|
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Internal ribosome entry segment-mediated initiation of c-Myc protein synthesis following genotoxic stress.
Topics: 5' Untranslated Regions; Blotting, Northern; Blotting, Western; Cell Survival; DNA Damage; DNA-Binding Proteins; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Ethyl Methanesulfonate; HeLa Cells; Humans; Immunosuppressive Agents; Luciferases; Mitogen-Activated Protein Kinases; Mitomycin; p38 Mitogen-Activated Protein Kinases; Peptide Chain Initiation, Translational; Phosphorylation; Precipitin Tests; Protein Biosynthesis; Protein Kinases; Protein Synthesis Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myc; Ribosomes; RNA, Messenger; Sirolimus; TOR Serine-Threonine Kinases; Transcription Factors | 2001 |
Sirolimus and intraoperative hyperthermic peritoneal chemoperfusion with mitomycin-C do not impair healing of bowel anastomoses.
Topics: Anastomosis, Surgical; Animals; Antibiotics, Antineoplastic; Cell Proliferation; Digestive System Neoplasms; Female; Humans; Hyperthermia, Induced; Immunosuppressive Agents; Intestinal Mucosa; Intestines; Mitomycin; Models, Animal; Perfusion; Peritoneal Cavity; Peritoneal Neoplasms; Sirolimus; Sus scrofa; Wound Healing | 2008 |
Mesenchymal stem cell and immunosuppressive drug interactions.
Topics: Cell Division; Cyclosporine; Drug Interactions; Humans; Immunosuppressive Agents; Mesenchymal Stem Cells; Mitomycin; Mycophenolic Acid; Sirolimus | 2009 |
CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Antigen-Presenting Cells; B-Lymphocytes; CD4-Positive T-Lymphocytes; Cell Proliferation; Dendritic Cells; Forkhead Transcription Factors; Interleukin-2 Receptor alpha Subunit; Interleukin-7 Receptor alpha Subunit; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mitomycin; Polymerase Chain Reaction; Sirolimus; T-Lymphocytes, Regulatory | 2010 |
Rapamycin-enhanced mitomycin C-induced apoptotic death is mediated through the S6K1-Bad-Bak pathway in peritoneal carcinomatosis.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-Associated Death Protein; Cell Line, Tumor; Humans; Mice; Mice, Nude; Mitomycin; Peritoneal Neoplasms; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus | 2014 |
Poor outcomes after liver transplantation in patients with incidental cholangiocarcinoma irrespective of tumor localization.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Calcineurin Inhibitors; Cholangiocarcinoma; Combined Modality Therapy; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Gemcitabine; Humans; Immunosuppressive Agents; Incidental Findings; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prognosis; Sirolimus; Survival Analysis; Treatment Outcome | 2014 |
The Suppression of Wound Healing Response with Sirolimus and Sunitinib Following Experimental Trabeculectomy in a Rabbit Model.
Topics: Alkylating Agents; Angiogenesis Inhibitors; Animals; Disease Models, Animal; Fibroblast Growth Factor 2; Fibroblast Growth Factors; Immunosuppressive Agents; Indoles; Male; Mitomycin; Platelet-Derived Growth Factor; Pyrroles; Rabbits; Sirolimus; Sunitinib; Trabecular Meshwork; Trabeculectomy; Transforming Growth Factor beta; Wound Healing | 2016 |
An immunotherapeutic strategy for prolonging graft survival in mice.
Topics: Adoptive Transfer; Animals; Antibodies, Monoclonal; Blood Transfusion; Cells, Cultured; Combined Modality Therapy; Graft Survival; Heart Transplantation; Humans; Immunization; Immunologic Memory; Immunotherapy; Isoantigens; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitomycin; OX40 Ligand; Sirolimus; T-Lymphocytes, Regulatory | 2015 |
Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Survival; Cyclosporine; Drug Therapy, Combination; Female; Fluorouracil; Hepatocytes; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis; Liver Transplantation; Male; Mice; Mice, Inbred C57BL; Middle Aged; Mitomycin; Semustine; Sirolimus; Tacrolimus | 2015 |
Fanconi anemia and mTOR pathways functionally interact during stalled replication fork recovery.
Topics: Aphidicolin; Cell Survival; DNA; DNA Repair; DNA Replication; Fanconi Anemia; Fanconi Anemia Complementation Group D2 Protein; Fibroblasts; Genome, Human; Genomic Instability; Humans; Hydroxyurea; Mitomycin; Primary Cell Culture; Protein Binding; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2021 |